Latest filing published 11 Jun 2007 for KERYX BIOPHARMACEUTICALS INC, €4,828.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Stier: trading record in brief
Mark Stier is a declared insider of Keryx Biopharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 7 June 2007.
On the market, this insider has only ever bought: 2 purchases, €20k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 11 June 2007, reports an open-market purchase of €4,828 in Keryx Biopharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Stier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 600 shares@ US$10.75Common StockSEC:0001144204-07-031269:0Canonical exit: 5 Sept 2007 (T+90)
- 1,900 shares@ US$10.77Common StockSEC:0001144204-07-031269:1Canonical exit: 5 Sept 2007 (T+90)
2 of 2 declarations
